Table 2.

Prevalence of elevated ASCVD risk in US Adults, aged 30–49 by risk factors: NHANES 1999–00 to 2011–12 (n=9,608)

Age Group (years)	Male			Female
	Smokers	Non-smokers, Hypertension	Non-smokers, No Hypertension	Smokers	Non-smokers, Hypertension	Non-smokers, No Hypertension
30–34	8.4% (5.5%–12.5%)	2.0% (0.3%–13.2%)	0.0% (0.0%–0.5%*)	19.5% (14.0%–26.5%)	0.0% (0.0%–4.0%*)	0.0% (0.0%–0.4%*)
35–39	25.6% (21.1%–30.7%)	2.5% (1.4%–4.7%)	0.2% (0.0%–0.7%)	13.9% (10.4%–18.5%)	0.7% (0.2%–2.8%)	0.1% (0.0%–1.0%)
40–44	53.1% (47.2%–58.9%)	6.9% (4.4%–10.6%)	1.2% (0.5%–3.2%)	13.3% (8.9%–19.4%)	1.9% (0.9%–4.1%)	0.0% (0.0%–0.5%*)
45–49	75.9% (69.1%–81.6%)	29.3% (22.6%–37.1%)	4.6% (2.7%–7.6%)	18.5% (13.5%–25.0%)	3.7% (1.7%–7.8%)	0.0% (0.0%–0.6%*)

^#Risk calculated using 2013 ACC/AHA Sex and Race specific Pooled Cohort Equations.

^*Confidence Intervals estimated using exact binomial methods.

Brackets show 95% confidence intervals for that subgroup.

Shaded cells represent low prevalence subgroups.